InvestorsHub Logo
Followers 240
Posts 12423
Boards Moderated 0
Alias Born 08/14/2003

Re: marzan post# 281874

Thursday, 05/07/2020 7:39:03 PM

Thursday, May 07, 2020 7:39:03 PM

Post# of 705610
I admit, I haven't followed the company for years, give them zero credibility. I considered Multikine to be a cure in search of a disease, and perhaps this time they hit it. If they did, and you're invested and do well, congratulations, I've just seen them fail so many times that I can't consider ever investing again, but I did once, when they were after AIDS, and the symbol was HIV.

There is little doubt in my mind that NWBO's trial results will show that DCVax-L is approvable, and I believe it will be approved if not by all the regulators, by some of them. Our FDA could be a holdout that want's additional trials run. People living sometimes means little to them if some bizarre figure they want fails to be met. I can't say how many drugs I've seen approved by them after additional trials were run, and cumulatively additional billions were spent on drugs I was certain would be approve, and in many cases were approved elsewhere. Cutting the costs of running drug trials would be the first step I'd take at reducing the costs of drugs, and lowering the cost of healthcare.

Gary
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News